41. Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478). (May 2019) Authors: Philis-Tsimikas, Athena; Stratton, Irene; Nørgård Troelsen, Lone; Anker Bak, Britta; Leiter, Lawrence A. Journal: Journal of diabetes science and technology Issue: Volume 13:Number 3(2019:May) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment. Issue 11 (7th June 2017) Authors: Hanefeld, Markolf; Arteaga, Juan M.; Leiter, Lawrence A.; Marchesini, Giulio; Nikonova, Elena; Shestakova, Marina; Stager, William; Gómez‐Huelgas, Ricardo Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 11(2017) Page Start: 1594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Issue 4 (6th November 2022) Authors: Connelly, Kim A.; Mazer, C. David; Puar, Pankaj; Teoh, Hwee; Wang, Chao-Hung; Mason, Tamique; Akhavein, Farhad; Chang, Ching-Wen; Liu, Min-Hui; Yang, Ning-I; Chen, Wei-Siang; Juan, Yu-Hsiang; Opingari, Erika; Salyani, Yaseen; Barbour, William; Pasricha, Aryan; Ahmed, Shamon; Kosmopoulos, Andrew; ... Journal: Circulation Issue: Volume 147:Issue 4(2023) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. (1st January 2023) Authors: Abtan, Jeremie; Bhatt, Deepak L.; Elbez, Yedid; Ducrocq, Gregory; Goto, Shinya; Smith, Sidney C.; Ohman, E. Magnus; Eagle, Kim A.; Fox, Kim; Harrington, Robert A.; Leiter, Lawrence A.; Mehta, Shamir R.; Simon, Tabassome; Petrov, Ivo; Sinnaeve, Peter R.; Pais, Prem; Lev, Eli; Bueno, Héctor; Wilson... Journal: International journal of cardiology Issue: Volume 370(2023) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin. Issue 6 (8th April 2019) Authors: Vilsbøll, Tina; Blevins, Thomas C.; Jodar, Esteban; Poulter, Neil; Tentolouris, Nikolaos; Ross Agner, Bue F.; Lehmann, Lucine; Leiter, Lawrence A. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 6(2019) Page Start: 1506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements. (3rd August 2022) Authors: Miller, Michael; Tokgozoglu, Lale; Parhofer, Klaus G.; Handelsman, Yehuda; Leiter, Lawrence A.; Landmesser, Ulf; Brinton, Eliot A.; Catapano, Alberico L. Journal: Expert review of cardiovascular therapy Issue: Volume 20:Number 8(2022) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan‐O trial testing a titratable fixed‐ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents. Issue 12 (7th July 2017) Authors: Davies, Melanie J.; Leiter, Lawrence A.; Guerci, Bruno; Grunberger, George; Ampudia‐Blasco, F. Javier; Yu, Christine; Stager, William; Niemoeller, Elisabeth; Souhami, Elisabeth; Rosenstock, Julio Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 12(2017) Page Start: 1798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial. Issue 2 (17th October 2021) Authors: Pieber, Thomas R.; Bajaj, Harpreet S.; Heller, Simon R.; Jia, Ting; Khunti, Kamlesh; Klonoff, David C.; Ladelund, Steen; Leiter, Lawrence A.; Wagner, Lily; Philis‐Tsimikas, Athena Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 2(2022) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions. Issue 10 (10th March 2020) Authors: Sharma, Abhinav; Pagidipati, Neha J.; Califf, Robert M.; McGuire, Darren K.; Green, Jennifer B.; Demets, Dave; George, Jyothis Thomas; Gerstein, Hertzel C.; Hobbs, Todd; Holman, Rury R.; Lawson, Francesca C.; Leiter, Lawrence A.; Pfeffer, Marc A.; Reusch, Jane; Riesmeyer, Jeffrey S.; Roe, Matthew... Journal: Circulation Issue: Volume 141:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation. (February 2016) Authors: Leiter, Lawrence A.; Shestakova, Marina V.; Trubitsyna, Natalya P.; Piletič, Milivoj; Satman, Ilhan Journal: Diabetes research and clinical practice Issue: Volume 112(2016) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗